RecruitingPhase 2NCT05961761

Propranolol and Pembrolizumab in Advanced Soft Tissue Sarcoma Patients

Studying Angiosarcoma

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Niels Junker
Principal Investigator
Niels Junker, MD, PhD
Herlev and Gentofte Hospital
Intervention
Propranolol(drug)
Enrollment
80 enrolled
Eligibility
18 years · All sexes
Timeline
2021 – 2028

Study locations (4)

Collaborators

Aarhus University Hospital · Oslo University Hospital · Karolinska University Hospital

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05961761 on ClinicalTrials.gov

Other trials for Angiosarcoma

Additional recruiting or active studies for the same condition.

See all trials for Angiosarcoma →

← Back to all trials